- Home
- ETO vs MRVI Comparison
ETO vs MRVI Comparison
Compare ETO & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETO
- MRVI
- Stock Information
- Founded
- ETO 2004
- MRVI 2014
- Country
- ETO United States
- MRVI United States
- Employees
- ETO N/A
- MRVI N/A
- Industry
- ETO Investment Managers
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- ETO Finance
- MRVI Health Care
- Exchange
- ETO Nasdaq
- MRVI Nasdaq
- Market Cap
- ETO 455.8M
- MRVI 376.2M
- IPO Year
- ETO N/A
- MRVI 2020
- Fundamental
- Price
- ETO $27.45
- MRVI $2.88
- Analyst Decision
- ETO
- MRVI Hold
- Analyst Count
- ETO 0
- MRVI 9
- Target Price
- ETO N/A
- MRVI $5.25
- AVG Volume (30 Days)
- ETO 26.5K
- MRVI 967.6K
- Earning Date
- ETO 01-01-0001
- MRVI 11-06-2025
- Dividend Yield
- ETO 6.67%
- MRVI N/A
- EPS Growth
- ETO N/A
- MRVI N/A
- EPS
- ETO N/A
- MRVI N/A
- Revenue
- ETO N/A
- MRVI $219,830,000.00
- Revenue This Year
- ETO N/A
- MRVI N/A
- Revenue Next Year
- ETO N/A
- MRVI $7.23
- P/E Ratio
- ETO N/A
- MRVI N/A
- Revenue Growth
- ETO N/A
- MRVI N/A
- 52 Week Low
- ETO $19.85
- MRVI $1.67
- 52 Week High
- ETO $25.21
- MRVI $9.50
- Technical
- Relative Strength Index (RSI)
- ETO 51.45
- MRVI 62.30
- Support Level
- ETO $27.37
- MRVI $2.61
- Resistance Level
- ETO $27.83
- MRVI $2.98
- Average True Range (ATR)
- ETO 0.23
- MRVI 0.17
- MACD
- ETO -0.01
- MRVI 0.04
- Stochastic Oscillator
- ETO 62.38
- MRVI 86.23
About ETO Eaton Vance Tax-Advantage Global Dividend Opp
Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.